Micell Technologies

About:

Micell Technologies is a biomedical device company developing interventional cardiology systems for vascular drug delivery.

Website: http://www.micell.com

Top Investors: GE Capital, St. Jude Medical, Five Points Capital, Gladwyne Partners, SIP (Strategic Investment Partners Ltd.)

Description:

Micell Technologies, Inc., a biomedical device company, develops interventional cardiology systems for vascular drug delivery. It develops MiStent, a drug-eluting stent that allows control of drug release and pharmacokinetics. The company was founded in 1995 and is based in Raleigh, North Carolina.

Total Funding Amount:

$90.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

1995-01-01

Contact Email:

info(AT)micell.com

Founders:

James McClain

Number of Employees:

11-50

Last Funding Date:

2017-09-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai